Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Humira Biosimilar Drumbeats: Biocon Claims Edge For Adalimumab In US
Nov 21 2022
•
By
Anju Ghangurde
Biocon Well Placed To Debut Humira Biosimilar In The US • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip